A review of molecular events of cadmium-induced carcinogenesis

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 33, Issue 3, 2014, Pages 183-194

  Luevano, Joe ^a   Damodaran, Chendil ^b  

^a Paul L Foster School of Medicine   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Breast cancer; Cancer; Lung cancer; Malignant; Prostate cancer; Transformation

Indexed keywords

CADMIUM; DNA; REACTIVE OXYGEN METABOLITE; CARCINOGEN;

APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; CARCINOGENESIS; CELL PROLIFERATION; DISEASE ASSOCIATION; DNA REPAIR; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE EXPRESSION; HUMAN; IN VITRO STUDY; LONG TERM EXPOSURE; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; TOXICITY;

ANIMALS; AUTOPHAGY; CADMIUM; CARCINOGENESIS; CARCINOGENS, ENVIRONMENTAL; CELL PROLIFERATION; DNA REPAIR; EPIGENESIS, GENETIC; HUMANS;

EID: 84904805086     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.2014011075     Document Type: Article

References (92)

1. Meeting of the IARC working group on beryllium, cadmium, mercury and exposures in the glass manufacturing industry. Scand J Work Environ Health. 1993;19(5):360-3.
2. Roy SS, Mahapatra R, Rath S, Bajpai A, Singh V, Rath S, Nair N, Tripathy P, Gope RK, Sinha R, Costello A, Pagel C, Prost A. Improved neonatal survival after participatory learning and action with women's groups: a prospective study in rural eastern India. Bull World Health Organ. 2013;91(6):426-33B.
3. Cadmium and Certain Cadmium Compounds 8th Report on Carcinogen US Department of Health and Human Services, National Toxicology Program. 1998(II):III-405-III-8.
4. Kjellstrom T, Friberg L, Rahnster B. Mortality and cancer morbidity among cadmium-exposed workers. Environ Health Perspect. 1979;28:199-204.
5. Nordberg GF, Goyer RA, Clarkson TW. Impact of effects of acid precipitation on toxicity of metals. Environ Health Perspect. 1985;63:169-80.
6. Satarug S, Moore MR. Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect. 2004;112(10):1099-103.
7. Suwazono YL, Kido T, Nakagawa H, Nishijo M, Honda R, Kobayashi E, Dochi M, Nogawa K. Biological half-life of cadmium in the urine of inhabitants after cessation of cadmium exposure. Biomarkers. 2009;14(2):77-81.
8. Satarug S. Long-term exposure to cadmium in food and cigarette smoke, liver effects and hepatocellular carcinoma. Curr Drug Metab. 2012;13(3):257-71.
9. Takenaka S, Oldiges H, Konig H, Hochrainer D, Oberdorster G. Carcinogenicity of cadmium chloride aerosols in W rats. J Natl Cancer Inst. 1983;70(2):367-73.
10. Waalkes MP, Rehm S, Perantoni AO, Coogan TP. Cadmium exposure in rats and tumours of the prostate. IARC Sci Publ. 1992(118):391-400.
11. Julin B, Wolk A, Bergkvist L, Bottai M, Akesson A. Dietary cadmium exposure and risk of postmenopausal breast cancer: a population-based prospective cohort study. Cancer Res. 2012;72(6):1459-66.
12. Basu M, Mukhopadhyay S, Chatterjee U, Roy SS. FGF16 promotes invasive behavior of SKOV-3 ovarian cancer cells through activation of mitogenactivated protein kinase (MAPK) signaling pathway. J Biol Chem. 2014;289(3):1415-28.
13. Xu F, Wu MY, Safron NS, Roy SS, Jacobberger RM, Bindl DJ, Seo JH, Chang TH, Ma Z, Arnold MS. Highly stretchable carbon nanotube transistors with ion gel gate dielectrics. Nano Lett. 2014.
14. Roy SS, Chakraborty P, Bhattacharya S. Intervention in cyclophosphamide induced oxidative stress and DNA damage by a flavonyl-thiazolidinedione based organoselenocyanate and evaluation of its efficacy during adjuvant therapy in tumor bearing mice. Eur J Med Chem. 2013;73C:195-209.
15. Meier B, Dumez JN, Stevanato G, Hill-Cousins JT, Roy SS, Håkansson P, Mamone S, Brown RC, Pileio G, Levitt MH. Long-lived nuclear spin states in methyl groups and quantum-rotor-induced polarization. J Am Chem Soc. 2013;135(50):18746-9.
16. Mati SS, Roy SS, Chall S, Bhattacharya S, Bhattacharya SC. Unveiling the groove binding mechanism of a biocompatible naphthalimide-based organoselenocyanate with calf thymus DNA: an ex vivo fluorescence imaging application appended by biophysical experiments and molecular docking simulations. J Phys Chem B. 2013;117(47):14655-65.
17. Agyin JK, Santhamma B, Roy SS. Design, synthesis, and biological evaluation of bone-targeted proteasome inhibitors for multiple myeloma. Bioorg Med Chem Lett. 2013;23(23):6455-8.
18. Roy SS, Patra M, Nandy SK, Banik M, Dasgupta R, Basu T. In vitro holdase activity of E. coli small heat-shock proteins IbpA, IbpB and IbpAB: a biophysical study with some unconventional techniques. Protein Pept Lett. 2014;21(6):564-71.
19. Achanzar WE, Diwan BA, Liu J, Quader ST, Webber MM, Waalkes MP. Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res. 2001;61(2):455-8.
20. Waalkes MP. Cadmium carcinogenesis. Mutat Res. 2003;533(1-2):107-20.
21. Waisberg M, Joseph P, Hale B, Beyersmann D. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology. 2003;192(2-3):95-117.
22. Giaginis C, Gatzidou E, Theocharis S. DNA repair systems as targets of cadmium toxicity. Toxicol Appl Pharmacol. 2006;213(3):282-90.
23. Aimola P, Carmignani M, Volpe AR, Di Benedetto A, Claudio L, Waalkes MP, van Bokhoven A, Tokar EJ, Claudio PP. Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. PLoS One. 2012;7(3):e33647.
24. Meplan C, Mann K, Hainaut P. Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. J Biol Chem. 1999;274(44):31663-70.
25. Hartmann M, Hartwig A. Disturbance of DNA damage recognition after UV-irradiation by nickel(II) and cadmium(II) in mammalian cells. Carcinogenesis. 1998;19(4):617-21.
26. Asmuss M, Mullenders LH, Eker A, Hartwig A. Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair. Carcinogenesis. 2000;21(11):2097-104.
27. Souza V, Escobar Md Mdel C, Gómez-Quiroz L, Bucio L, Hernández E, Cossio EC, Gutiérrez-Ruiz MC. Acute cadmium exposure enhances AP-1 DNA binding and induces cytokines expression and heat shock protein 70 in HepG2 cells. Toxicology. 2004;197(3):213-28.
28. Freitas M, Fernandes E. Zinc, cadmium and nickel increase the activation of NF-kappaB and the release of cytokines from THP-1 monocytic cells. Metallomics. 2011;3(11):1238-43.
29. Yang Z, Yang S, Qian SY, Hong JS, Kadiiska MB, Tennant RW, Waalkes MP, Liu J. Cadmium-induced toxicity in rat primary mid-brain neuroglia cultures: role of oxidative stress from microglia. Toxicol Sci. 2007;98(2):488-94.
30. Xie J, Shaikh ZA. Cadmium-induced apoptosis in rat kidney epithelial cells involves decrease in nuclear factor-κ B activity. Toxicol Sci. 2006;91(1):299-308.
31. Severson PL, Tokar EJ, Vrba L, Waalkes MP, Futscher BW. Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation. Epigenetics. 2012;7(11):1238-48.
32. Mao WP, Zhang NN, Zhou FY, Li WX, Liu HY, Feng J, Zhou L, Wei CJ, Pan YB, He ZJ. Cadmium directly induced mitochondrial dysfunction of human embryonic kidney cells. Hum Exp Toxicol. 2011;30(8):920-9.
33. Bagchi D, Vuchetich PJ, Bagchi M, Hassoun EA, Tran MX, Tang L, Stohs SJ. Induction of oxidative stress by chronic administration of sodium dichromate [chromium VI] and cadmium chloride [cadmium II] to rats. Free Radic Biol Med. 1997;22(3):471-8.
34. Roy SS, Gonugunta VK, Bandyopadhyay A, Rao MK, Goodall GJ, Sun LZ, Tekmal RR, Vadlamudi RK. Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer. Oncogene. 2013.
35. Manca D, Ricard AC, Tra HV, Chevalier G. Relation between lipid peroxidation and inflammation in the pulmonary toxicity of cadmium. Arch Toxicol. 1994;68(6):364-9.
36. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004;266(1-2):37-56.
37. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160(1):1-40.
38. Liu Y, Roy SS, Nebie RH, Zhang Y, Nair MG. Functional food quality of Curcuma caesia, Curcuma zedoaria and Curcuma aeruginosa endemic to northeastern India. Plant Foods Hum Nutr. 2013;68(1):72-7.
39. Basu M, Roy SS. Wnt/beta-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3. J Biol Chem. 2013;288(6):4355-67.
40. Bohara V, Raut L, Badarkhe G, Roy SS, Chaudhuri U. Homozygosity for the severe beta(+)- thalassemia mutation [IVS-I-5 (G>C)] causes the phenotype of thalassemia trait: an extremely rare presentation. Hemoglobin. 2013;37(1):101-5.
41. Ghosh P, Roy SS, Chakraborty P, Ghosh S, Bhattacharya S. Effects of organoselenium compound 2-(5-selenocyanato-pentyl)-benzo[de]isoquinoline 1,3-dione on cisplatin induced nephrotoxicity and genotoxicity: an investigation of the influence of the compound on oxidative stress and antioxidant enzyme system. Biometals. 2013;26(1):61-73.
42. Arriazu R, Duran E, Pozuelo JM, Santamaria L. Expression of lysophosphatidic acid receptor 1 and relation with cell proliferation, apoptosis, and angiogenesis on preneoplastic changes induced by cadmium chloride in the rat ventral prostate. PLoS One. 2013;8(2):e57742.
43. Lin CE, Chen SU, Lin CC, Chang CH, Lin YC, Tai YL, Shen TL, Lee H. Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells. PLoS One. 2012;7(7):e41096.
44. Benbrahim-Tallaa L, Waterland RA, Dill AL, Webber MM, Waalkes MP. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ Health Perspect. 2007;115(10):1454-9.
45. Morrissey C, Buser A, Scolaro J, O'Sullivan J, Moquin A, Tenniswood M. Changes in hormone sensitivity in the ventral prostate of aging Sprague- Dawley rats. J Androl. 2002;23(3):341-51.
46. Arunkumar A, Vijayababu MR, Venkataraman P, Senthilkumar K, Arunakaran J. Chemoprevention of rat prostate carcinogenesis by diallyl disulfide, an organosulfur compound of garlic. Biol Pharm Bull. 2006;29(2):375-9.
47. Pollard M, Wolter W, Sun L. Diet and the duration of testosterone-dependent prostate cancer in Lobund- Wistar rats. Cancer Lett. 2001;173(2):127-31.
48. Bosland MC. Use of animal models in defining efficacy of chemoprevention agents against prostate cancer. Eur Urol. 1999;35(5-6):459-63.
49. Waalkes MP, Rehm S, Riggs CW, Bare RM, Devor DE, Poirier LA, Wenk ML, Henneman JR, Balaschak MS Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of tumor induction in the prostate and testes and at the injection site. Cancer Res. 1988;48(16):4656-63.
50. Waalkes MP, Rehm S, Riggs CW, Bare RM, Devor DE, Poirier LA, Wenk ML, Henneman JR. Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of effects of zinc on tumor induction in the prostate, in the testes, and at the injection site. Cancer Res. 1989;49(15):4282-8.
51. Waalkes MP, Anver M, Diwan BA. Carcinogenic effects of cadmium in the noble (NBL/Cr) rat: induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative lesions of the dorso- lateral prostate. Toxicol Sci. 1999;52(2):154-61.
52. Waalkes MP, Anver MR, Diwan BA. Chronic toxic and carcinogenic effects of oral cadmium in the Noble (NBL/Cr) rat: induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate, and testes. J Toxicol Environ Health A. 1999;58(4):199-214.
53. Bertin G, Averbeck D. Cadmium: cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review). Biochimie. 2006;88(11):1549-59.
54. Beyersmann D, Hechtenberg S. Cadmium, gene regulation, and cellular signalling in mammalian cells. Toxicol Appl Pharmacol. 1997;144(2):247-61.
55. Yamashita H1, Tripathi M, Jourquin J, Kam Y, Liu S, Weidow B, Quaranta V. Lysophosphatidic acid upregulates Laminin-332 expression during A431 cell colony dispersal. J Oncol. 2010;(10):1-8.
56. Chen SU, Chou CH, Chao KH, Lee H, Lin CW, Lu HF, Yang YS. Lysophosphatidic acid up-regulates expression of growth-regulated oncogene-α, interleukin- 8, and monocyte chemoattractant protein-1 in human first-trimester trophoblasts: possible roles in angiogenesis and immune regulation. Endocrinology. 2010;151(1):369-79.
57. Guo R, Kasbohm EA, Arora P, Sample CJ, Baban B, Sud N, Sivashanmugam P, Moniri NH, Daaka Y. Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells. Endocrinology. 2006;147(10):4883-92.
58. Achanzar WE, Achanzar KB, Lewis JG, Webber MM, Waalkes MP. Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. Toxicol Appl Pharmacol. 2000;164(3):291-300.
59. Achanzar WE, Webber MM, Waalkes MP. Altered apoptotic gene expression and acquired apoptotic resistance in cadmium-transformed human prostate epithelial cells. Prostate. 2002;52(3):236-44.
60. Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol. 1998;16:395-419.
61. Nunez G, Benedict MA, Hu Y, Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 1998;17(25):3237-45.
62. Qu W, Ke H, Pi J, Broderick D, French JE, Webber MM, Waalkes MP. Acquisition of apoptotic resistance in cadmium-transformed human prostate epithelial cells: Bcl-2 overexpression blocks the activation of JNK signal transduction pathway. Environ Health Perspect. 2007;115(7):1094-100.
63. Gaddipati JP, Rajeshkumar NV, Grove JC, Maharaj SV, Centeno JA, Maheshwari RK, Jonas WB. Low-dose cadmium exposure reduces human prostate cell transformation in culture and up-regulates metallothionein and MT-1G mRNA. Nonlinearity Biol Toxicol Med. 2003;1(2):199-212.
64. Albrecht AL, Singh RK, Somji S, Sens MA, Sens DA, Garrett SH. Basal and metal-induced expression of metallothionein isoform 1 and 2 genes in the RWPE-1 human prostate epithelial cell line. J Appl Toxicol. 2008;28(3):283-93.
65. Misra UK, Gawdi G, Pizzo SV. Induction of mitogenic signalling in the 1LN prostate cell line on exposure to submicromolar concentrations of cadmium+. Cell Signal. 2003;15(11):1059-70.
66. Martin MB, Reiter R, Pham T, Avellanet YR, Camara J, Lahm M, Pentecost E, Pratap K, Gilmore BA, Divekar S, Dagata RS, Bull JL, Stoica A. Estrogen- like activity of metals in MCF-7 breast cancer cells. Endocrinology. 2003;144(6):2425-36.
67. Choe SY, Kim SJ, Kim HG, Lee JH, Choi Y, Lee H, Kim Y. Evaluation of estrogenicity of major heavy metals. Sci Total Environ. 2003;312(1-3):15-21.
68. Antila E, Mussalo-Rauhamaa H, Kantola M, Atroshi F, Westermarck T. Association of cadmium with human breast cancer. Sci Total Environ. 1996;186(3):251-6.
69. Strumylaite L, Mechonosina K, Tamasauskas S. Environmental factors and breast cancer. Medicina (Kaunas). 2010;46(12):867-73.
70. Stoica A, Katzenellenbogen BS, Martin MB. Activation of estrogen receptor-α by the heavy metal cadmium. Mol Endocrinol. 2000;14(4):545-53.
71. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, Reiter R, Trock B, Paik S, Martin MB. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med. 2003;9(8):1081-4.
72. Ponce E, Aquino NB, Louie MC. Chronic cadmium exposure stimulates SDF-1 expression in an ERα dependent manner. PLoS One. 2013;8(8):e72639.
73. Siewit CL, Gengler B, Vegas E, Puckett R, Louie MC. Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERα and c-Jun. Mol Endocrinol. 2010;24(5):981-92.
74. Benbrahim-Tallaa L, Tokar EJ, Diwan BA, Dill AL, Coppin JF, Waalkes MP. Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype. Environ Health Perspect. 2009;117(12):1847-52.
75. Sinha Roy S, Mukherjee S, Mukhopadhyay S, Das SK. Differential effect of cadmium on cholinephosphotransferase activity in normal and cancerous human mammary epithelial cell lines. Mol Cancer Ther. 2004;3(2):199-204.
76. Field RW, Withers BL. Occupational and envi-ronmental causes of lung cancer. Clin Chest Med. 2012;33(4):681-703.
77. Waalkes MP. Cadmium carcinogenesis in review. J Inorg Biochem. 2000;79(1-4):241-4.
78. Person RJ, Tokar EJ, Xu Y, Orihuela R, Ngalame NN, Waalkes MP. Chronic cadmium exposure in vitro induces cancer cell characteristics in human lung cells. Toxicol Appl Pharmacol. 2013.
79. Lei YX, Wei L, Wang M, Wu GR, Li M. Malignant transformation and abnormal expression of eukaryotic initiation factor in bronchial epithelial cells induced by cadmium chloride. Biomed Environ Sci. 2008;21(4):332-8.
80. Demirhan O, Tastemir D, Hasturk S, Kuleci S, Hanta I. Alterations in p16 and p53 genes and chromosomal findings in patients with lung cancer: fluorescence in situ hybridization and cytogenetic studies. Cancer Epidemiol. 2010;34(4):472-7.
81. Suzuki Y, Oonishi T, Kudo T, Doi H. LKB1, TP16, EGFR, and KRAS somatic mutations in lung adenocarcinomas from a Chiba Prefecture, Japan cohort. Drug Discov Ther. 2012;6(1):24-30.
82. Jin M, Inoue S, Umemura T, Moriya J, Arakawa M, Nagashima K, Kato H. Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II. Lung Cancer. 2001;34(2):207-18.
83. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, Ng B, Milosavljevic A, Gonzalez-Garay ML, Osborne JR, Meyer R, Shi X, Tang Y, Koboldt DC, Lin L, Abbott R, Miner TL, Pohl C, Fewell G, Haipek C, Schmidt H, Dunford-Shore BH, Kraja A, Crosby SD, Sawyer CS, Vickery T, Sander S, Robinson J, Winckler W, Baldwin J, Chirieac LR, Dutt A, Fennell T, Hanna M, Johnson BE, Onofrio RC, Thomas RK, Tonon G, Weir BA, Zhao X, Ziaugra L, Zody MC, Giordano T, Orringer MB, Roth JA, Spitz MR, Wistuba II, Ozenberger B, Good PJ, Chang AC, Beer DG, Watson MA, Ladanyi M, Broderick S, Yoshizawa A, Travis WD, Pao W, Province MA, Weinstock GM, Varmus HE, Gabriel SB, Lander ES, Gibbs RA, Meyerson M, Wilson RK. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008;455(7216):1069-75.
84. Kholodnyuk ID, Kozireva S, Kost-Alimova M, Kashuba V, Klein G, Imreh S. Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice. Int J Cancer. 2006;119(1):99-107.
85. Qu W, Fuquay R, Sakurai T, Waalkes MP. Acquisition of apoptotic resistance in cadmium-induced malignant transformation: specific perturbation of JNK signal transduction pathway and associated metallothionein overexpression. Mol Carcinog. 2006;45(8):561-71.
86. Eckschlager T, Adam V, Hrabeta J, Figova K, Kizek R. Metallothioneins and cancer. Curr Protein Pept Sci. 2009;10(4):360-75.
87. Jing Y, Liu LZ, Jiang Y, Zhu Y, Guo NL, Barnett J, Rojanasakul Y, Agani F, Jiang BH. Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells. Toxicol Sci. 2012;125(1):10-9.
88. Son YO, Wang L, Poyil P, Budhraja A, Hitron JA, Zhang Z, Lee JC, Shi X. Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK- 3β/β-catenin signaling. Toxicol Appl Pharmacol. 2012;264(2):153-60.
89. Zhou Z, Wang C, Liu H, Huang Q, Wang M, Lei Y. Cadmium induced cell apoptosis, DNA damage, decreased DNA repair capacity, and genomic instability during malignant transformation of human bronchial epithelial cells. Int J Med Sci. 2013;10(11):1485-96.
90. Roy SS, Sengupta S. A rare case of congenital cytomegalovirus infection in pregnancy. J Obstet Gynaecol India. 2012;62(1):70-2.
91. Wang SH, Shih YL, Kuo TC, Ko WC, Shih CM. Cadmium toxicity toward autophagy through ROSactivated GSK-3beta in mesangial cells. Toxicol Sci. 2009;108(1):124-31.
92. Park CH, Lee BH, Ahn SG, Yoon JH, Oh SH. Serine 9 and Tyrosine 216 phosphorylation of GSK-3β differentially regulates autophagy in acquired cadmium resistance. Toxicol Sci. 2013;135(2):380-9.